Cargando…
Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826807/ https://www.ncbi.nlm.nih.gov/pubmed/36632562 http://dx.doi.org/10.1016/j.jdcr.2022.12.002 |
| _version_ | 1784866935253499904 |
|---|---|
| author | Shahriari, Neda Mazori, Daniel R. Merola, Joseph F. |
| author_facet | Shahriari, Neda Mazori, Daniel R. Merola, Joseph F. |
| author_sort | Shahriari, Neda |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9826807 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98268072023-01-10 Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream Shahriari, Neda Mazori, Daniel R. Merola, Joseph F. JAAD Case Rep Case Report Elsevier 2022-12-15 /pmc/articles/PMC9826807/ /pubmed/36632562 http://dx.doi.org/10.1016/j.jdcr.2022.12.002 Text en © 2022 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. This is an open access.. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Report Shahriari, Neda Mazori, Daniel R. Merola, Joseph F. Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title | Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title_full | Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title_fullStr | Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title_full_unstemmed | Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title_short | Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title_sort | intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826807/ https://www.ncbi.nlm.nih.gov/pubmed/36632562 http://dx.doi.org/10.1016/j.jdcr.2022.12.002 |
| work_keys_str_mv | AT shahriarineda intravenousimmunoglobulinrefractorynecrobioticxanthogranulomasuccessfullytreatedwithtofacitinib2cream AT mazoridanielr intravenousimmunoglobulinrefractorynecrobioticxanthogranulomasuccessfullytreatedwithtofacitinib2cream AT merolajosephf intravenousimmunoglobulinrefractorynecrobioticxanthogranulomasuccessfullytreatedwithtofacitinib2cream |